Evidence map›Paper›PMID 19270724›Full record

ArticleOncogene2009

Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry.

H Lallet-Daher, M Roudbaraki, A Bavencoffe, P Mariot, F Gackière, G Bidaux, R Urbain, P Gosset, P Delcourt, L Fleurisse and 6 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 144 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Intermediate conductance CaFrontiers in insect science · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

H Lallet-DaherINSERM U800, Equipe Labellisée par la Ligue Nationale Contre le Cancer, Villeneuve d'Ascq, France.
M Roudbaraki
A Bavencoffe
P Mariot
F Gackière
G Bidaux
R Urbain
P Gosset
P Delcourt
L Fleurisse
C Slomianny
E Dewailly
B Mauroy
J L Bonnal
R Skryma
N Prevarskaya
La Ligue Contre le Cancer · FRInserm · FRGroupe Hospitalier de l'Institut Catholique de Lille · FRHôpital Saint-Philibert · FRUniversité de Lille · FRPierre Fabre (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating data point to K(+) channels as relevant players in controlling cell cycle progression and proliferation of human cancer cells, including prostate cancer (PCa) cells. However, the mechanism(s) by which K(+) channels control PCa cell proliferation remain illusive. In this study, using the techniques of molecular biology, biochemistry, electrophysiology and calcium imaging, we studied the expression and functionality of intermediate-conductance calcium-activated potassium channels (IK(Ca1)) in human PCa as well as their involvement in cell proliferation. We showed that IK(Ca1) mRNA and protein were preferentially expressed in human PCa tissues, and inhibition of the IK(Ca1) potassium channel suppressed PCa cell proliferation. The activation of IK(Ca1) hyperpolarizes membrane potential and, by promoting the driving force for calcium, induces calcium entry through TRPV6, a cation channel of the TRP (Transient Receptor Potential) family. Thus, the overexpression of the IK(Ca1) channel is likely to promote carcinogenesis in human prostate tissue.

Indexed as

BenzimidazolesCalciumCalcium ChannelsCell Line, TumorCell ProliferationCyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent Kinase Inhibitor p27G1 PhaseHumansIntermediate-Conductance Calcium-Activated Potassium ChannelsIntracellular Signaling Peptides and ProteinsMaleMembrane PotentialsProstatic NeoplasmsRNA, MessengerS100 Proteins1-ethyl-2-benzimidazolinoneBenzimidazolesCalciumCalcium ChannelsCDKN1A protein, humanCDKN1B protein, humanCyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent Kinase Inhibitor p27Intermediate-Conductance Calcium-Activated Potassium ChannelsIntracellular Signaling Peptides and ProteinsRNA, MessengerS100 ProteinsTRPV6 protein, humanTRPV Cation ChannelsTumor Suppressor Protein p53

Identifiers

PMID19270724
OpenAlexW2048489053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.